<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00824356</url>
  </required_header>
  <id_info>
    <org_study_id>110159</org_study_id>
    <secondary_id>723 PoC</secondary_id>
    <nct_id>NCT00824356</nct_id>
  </id_info>
  <brief_title>Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo</brief_title>
  <official_title>A Randomised, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Assess the Efficacy and Safety of Single Dose Intranasal GSK1004723 Compared With Placebo in an Allergen Challenge Chamber in Male Subjects With Seasonal Allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      This is a placebo-controlled, 3-period crossover study to assess the efficacy and safety of
      two single doses of an intranasal anti-histamine GSK1004723 compared with placebo in an
      allergen challenge chamber in male subjects with seasonal allergic
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in total nasal symptom score 0-4 hours post dose</measure>
    <time_frame>0-4 hours post dose</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>GSK1004726 (1000mg)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000mg aqueous suspension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intranasal spray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GSK1004723 (200mg)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 mg aqueous suspension</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GSK1004723 (200mg)</intervention_name>
    <description>Intranasal antihistamine.</description>
    <arm_group_label>GSK1004723 (200mg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Equivalent to GSK1004723 in presentation etc.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GSK1004723 (1000mg)</intervention_name>
    <description>Intranasal antihistamine.</description>
    <arm_group_label>GSK1004726 (1000mg)</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is healthy apart from seasonal allergic rhinitis, as determined by a
             physician. Can have mild asthma.

          -  Male

          -  Aged 18 - 65

          -  Weight 50kg+, BMI 19-32 kg/m2

          -  Exhibit response to Challenge Chamber and skin prick test.

          -  Non-smoker

          -  Capable of giving informed consent

        Exclusion Criteria:

          -  No nasal structural abnornmality/polyposis, surgery, infection.

          -  any respiratory disease, other than mild asthma or seasonal allergic rhinitis

          -  participated in another clinical study within 30 days.

          -  Subject has donated a unit of blood within 1 month

          -  Use of prescription or non-prescription drugs, including vitamins and st john's wort
             within 7 days of trial.

          -  History of sensitivty to drug

          -  History of alcohol/drug abuse within 12 months.

          -  Positive Hepatitis B antibody test

          -  Positive HIV antibody test

          -  Risk of non-compliance with study protocol

          -  Perenial allergic rhinitis

          -  Administration of oral, injectable or dermal corticosteriods within 8 weeks,
             intranasal or inhaled within 3 weeks.

          -  Past or present disease that may affect outcome, as judge by investigator Specific
             Immunotherapy within 2 years
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2009</study_first_submitted>
  <study_first_submitted_qc>January 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2009</study_first_posted>
  <last_update_submitted>June 18, 2009</last_update_submitted>
  <last_update_submitted_qc>June 18, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>Study Director</name_title>
    <organization>GSK</organization>
  </responsible_party>
  <keyword>Allergic Rhinitis</keyword>
  <keyword>Proof-of-Concept</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 3, 2017</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>March 14, 2017</submitted>
    <returned>April 24, 2017</returned>
    <submitted>July 11, 2017</submitted>
    <returned>February 5, 2018</returned>
    <submitted>February 15, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

